Study Suggests AYAs Treated for AML Have High Risk of Developing Long-Term Complications
November 25, 2020

These results suggested that adolescent and young adult patients treated for acute myeloid leukemia have a high risk of developing long-term health complications.

IFRT Appears Safe, Effective Standard of Care for Some Pediatric Patients with High-Risk cHL
November 25, 2020

A study presented at ASTRO suggested that response-based consolidation involved-field radiation therapy appears to be a safe and effective standard of care for a cohort of pediatric patients with high-risk classical Hodgkin lymphoma.

Study Finds Racial Disparities in ES-NSCLC Persist Despite Gains in Treatment
November 25, 2020

Though researchers found that Black patients with early-stage non-small cell lung cancer are now more likely to receive the most effective treatment compared to a decade ago, the disparity for this patient population persists.

Biomarker Blood Test Offers Diagnostic Potential for HPV-Related Cancers
November 25, 2020

“This might raise the potential of being able to detect disease recurrence much earlier than current clinical practice,” said Thomas Weiland, MD.

Emanuela Taioli, MD, PhD, on Disparities in Early-Stage Lung Cancer Diagnosis
November 24, 2020

Given that diagnosing lung cancer in its early stages can lead to successfully eliminating lung cancer with surgery alone, the importance of closing this disparity gap is critical.

Adagrasib Shows Promise in Phase 1/2 Trial for KRAS G12C Mutated NSCLC, CRC, and Other Solid Tumors
November 24, 2020

Adagrasib demonstrated an acceptable safety profile and promising clinical activity in pretreated patients with non-small cell lung cancer, colorectal cancer, and other solid tumors with a KRAS G12C mutation.